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Background/Evidence
Overuse of phlebotomy testing offers little to improve
patient outcomes but may subject patients to additional
morbidity. As a value-based system in healthcare
continues to evolve, providers and healthcare
organizations need to reduce non-value-added care
without compromising quality. Low-cost, high-frequency
tests are often ordered recurrently, unnecessarily, and
contribute to the high cost of health care. Reducing
unnecessary phlebotomy tests can cut costs without
compromising quality.
Clinical decision support systems (CDSSs) are
applications embedded in the electronic health record
with specific patient information that appear at the time of
ordering to assist health care professionals in decisionmaking to improve care.
Adoption of CDSSs have been successful in reducing
unnecessary radiologic imaging, overuse of antibiotics,
and Clostridium dificile testing.

Problem & Purpose
Type and screen testing is used to determine blood
compatibility and identify clinically significant antibodies
affecting blood transfusion compatibility.
Type and screen testing was suspected to be
unnecessarily ordered in our organization. Type and
screen tests are active for three days from the date the
specimen is collected, yet many patients receive orders
for repeat testing well in advance of the sample’s
expiration. Effects of CDSS have not been assessed
when applied specifically to type and screen tests.
The specific aims of our study were to:
• Determine the number of unnecessarily ordered type
and screen tests prior to and after implementation of a
CDSS.
• Determine the difference in estimated costs of
unnecessary type and screen testing based on testing
materials and labor expenses before versus after
implementation of a CDSS.
• Describe the unnecessary type and screen test
ordering practices of different provider type(s) (i.e.,
physician, advanced practice nurse [APRN], and
physician assistant [PA]) before and after
implementation of a CDSS.

Results

Conclusions

There were a total of 26,206 pre- and 25,053 postintervention specimens. Significantly fewer unnecessary
type and screen tests were ordered after the intervention
(12.3%, n=3,073) than before (14.1%, n=3,691; p<0.001;
Table 1), representing a reduction of 16.7%

Our study demonstrated that a CDSS impacted a variety
of provider types, reduced unnecessary phlebotomy tests,
and achieved yearly cost savings. To further improve test
ordering practices of all provider types, we recommend
additional interventions such as organizational support,
education, audits, and feedback.

Methods
Design: Our value improvement initiative used a
retrospective separate-sample pretest posttest design.
Sample: The total number of appropriate and
unnecessarily ordered type and screen tests from the
three-month pre-intervention and three-month postintervention period was used to determine effectiveness
of the CDSS. All unnecessarily ordered tests from the preand post- intervention periods were used for cost
estimation. Random selections of 801 tests before and
801 tests after the intervention were used to describe
ordering practices by provider type.

The results demonstrated an estimated yearly savings of
$142,612 (Table 2). The majority of the tests were
ordered by physicians (85.3% before and 83.1% after the
intervention) compared to APRNs and PAs (Table 3).
Table 1 Unnecessary Type and Screen Tests Ordered Before
Versus After Implementation of a CDSS

Setting: Large Mid-Atlantic urban academic medical
center.
Intervention: A CDSS to promote appropriate test
ordering was embedded in our computerized order entry
(CPOE) system. The CDSS appears when a type and
screen test is ordered informing the provider of the date
and time the current test expires (Figure 1).
Measurement: The total number of type and screen tests
was captured in a monthly aggregate report.
Unnecessary tests are those ordered and preformed prior
to the previous test’s expiration. Using data from the
CPOE, laboratory information, and transfusion software
systems, a customized report identified the unnecessary
tests.. Estimated cost of unnecessary tests used a
combination of direct costs and labor costs. Our office of
credentialing provided the total number of each provider
type employed at our medical center.
Analysis: Pre-intervention and post-intervention data
were compared using chi-square, time-drive activitybased costing estimate, and descriptive statistics. Level of
significance was set at 0.05.
Figure 1 CDSS for Type and Screen Test

Total n (%)

Appropriate Unnecessary
Statistic X2 p-value
order n (%) order n (%)

Pre-CDS
tool

26206 (100) 225151(85.9) 3691 (14.1)

Post-CDS
tool

25053 (100) 21980 (87.7)

36.98

Unnecessary laboratory testing continues in health care
and contributes to excessive health spending without
adding value. Phlebotomy testing is one example of how
providers can reduce waste and control healthcare costs
for low-cost, high-frequency tests.
In this era of precision healthcare, the upshot of ordering
the right test, at the right time, for the right reason can
reduce cost, reduce waste, improve quality and
satisfaction for patients.

<0.001

3073 (12.3)

Table 2 Estimated Cost of Unnecessary Type and Screen
Tests Ordered Before Versus After CDSS

Estimated cost of
unnecessary tests
during 3 month data
collection period
Estimated annual
cost of unnecessary
tests

Pre-CDSS

Post-CDSS

$212,936.00

$177,283.00

$851,744.00

$709,132.00

Estimated yearly
savings

$142,612

Table 3 Unnecessary Type and Screen Tests Ordered by
Provider Type Before Versus After Implementation of a CDSS
Total n (%)

Physician n (%)

APRN
n (%)

PA n (%)

Pre-CDSS

801 (50)

683 (85.3)

51 (6.4)

67 (8.4)

Post-CDSS

801 (50)

666 (83.1)

80 (10)

55 (6.9)

1602 (100)

1349 (84.2)

131 (8.2)

122 (7.6)

Total

Implications
Our study illustrates the effectiveness of CDSS as a
means of reducing unnecessary health care services.
CPOE is widely used in a variety of health care settings
and can incorporate CDSS to guide all provider types to
make judicious decisions at the time of care.
Until the establishment of national quality measures
aimed to control the number of low-cost, high-frequency
tests, health systems must find a way to reduce
unnecessary health services.

